HealthcareNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 1833498MDAI stock profile & AI dashboard →

13F Pro Quality Score

17.5/100

Rank #2,824 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

MDAI Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Spectral AI, Inc. (MDAI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MDAI at 17.5/100 on a 32-signal composite quality model, placing it at rank #2,824 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Spectral AI, Inc. reports quarterly revenue of $3.5M, net income of $-4.2M. Top institutional holders of MDAI by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Highlander Partners, L.P., MARSHALL WACE, LLP, based on the most recent SEC filings. MDAI trades on the Nasdaq exchange and files with the SEC under CIK 1833498. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDAI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Spectral AI, Inc. directly from SEC EDGAR. Spectral AI, Inc.'s 13F Pro composite quality score has ranged between 10 and 29 since 2024, currently 17.5 — a stable long-term trajectory across 35 quarterly and live scoring snapshots.

Revenue

Q2 2026

$3.5M

Net Income

Q2 2026

$-4.2M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-33.6% YoY
$19.6MFY 2025
FY22 $25.4MFY23 $18.1MFY24 $29.6MFY25 $19.6M

Net Income

+50.1% YoY
$-7.6MFY 2025
FY22 $-2.9MFY23 $-20.9MFY24 $-15.2MFY25 $-7.6M

Operating Income

-30.7% YoY
$-8.6MFY 2025
FY22 $-2.6MFY23 $-13.0MFY24 $-6.6MFY25 $-8.6M

EPS (Diluted)

+65.9% YoY
$-0.29FY 2025
FY22 $-0.02FY23 $-1.48FY24 $-0.85FY25 $-0.29

Total Assets

+77.0% YoY
$21.4MFY 2025
FY22 $18.7MFY23 $10.7MFY24 $12.1MFY25 $21.4M

Total Debt

+231.9% YoY
$9.3MFY 2025
FY22 FY23 FY24 $2.8MFY25 $9.3M

Op. Cash Flow

-7.8% YoY
$-9.9MFY 2025
FY22 $-1.2MFY23 $-13.2MFY24 $-9.2MFY25 $-9.9M

Get alerted when MDAI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Spectral AI, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of MDAI

Put MDAI on your watchlist

Track score changes the day Spectral AI, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is MDAI a good stock to buy?

13F Pro's AI-powered analysis of Spectral AI, Inc. (MDAI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MDAI are available on the MDAI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. MDAI is classified as a small company.

Which hedge funds own MDAI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MDAI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Spectral AI, Inc.'s investment landscape.